Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives
Annalisa Chianese, Biagio Santella, Annalisa Ambrosino, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2761-2761
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1
Carla Zannella, Rosa Giugliano, Annalisa Chianese, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1263-1263
Open Access | Times Cited: 75
Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
Zhi Zhu, A. J. Robert McGray, Weijian Jiang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 61
Interactions between circRNAs and miR-141 in Cancer: From Pathogenesis to Diagnosis and Therapy
Małgorzata Guz, Witold Jeleniewicz, Marek Cybulski
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11861-11861
Open Access | Times Cited: 13
Photodynamic augmentation of oncolytic virus therapy for central nervous system malignancies
K. Shimizu, Andranik Kahramanian, Muzammil Arif Din Abdul Jabbar, et al.
Cancer Letters (2023) Vol. 572, pp. 216363-216363
Open Access | Times Cited: 11
Epigenetic modulation by oncolytic viruses: Implications for cancer therapeutic efficacy
Muhammad Haris Sultan, Qi Zhang, Hao Jin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189270-189270
Closed Access
Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Julio Aguilar, et al.
Pathogens (2021) Vol. 10, Iss. 11, pp. 1440-1440
Open Access | Times Cited: 21
Genetic Therapy and Molecular Targeted Therapy in Oncology: Safety, Pharmacovigilance, and Perspectives for Research and Clinical Practice
Sabrina Orzetti, Federica Tommasi, Antonella Bertola, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3012-3012
Open Access | Times Cited: 15
Epigenetic-Mediated Antimicrobial Resistance: Host versus Pathogen Epigenetic Alterations
Jibran Sualeh Muhammad, Naveed Ahmed Khan, Sutherland K. Maciver, et al.
Antibiotics (2022) Vol. 11, Iss. 6, pp. 809-809
Open Access | Times Cited: 15
Immunotherapy: A new target for cancer cure (Review)
Fuqian Zhao, Dao-fu Shen, Mingquan Shang, et al.
Oncology Reports (2023) Vol. 49, Iss. 5
Open Access | Times Cited: 8
Epigenetic Rewiring of Metastatic Cancer to the Brain: Focus on Lung and Colon Cancers
Annamaria Morotti, Francesco Gentile, Gianluca Lopez, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2145-2145
Open Access | Times Cited: 7
Sindbis Virus Vaccine Platform: A Promising Oncolytic Virus-Mediated Approach for Ovarian Cancer Treatment
Christine Pampeno, Silvana Opp, Alicia Hurtado, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2925-2925
Open Access | Times Cited: 2
Autophagy-based therapy for hepatocellular carcinoma: from standard treatments to combination therapy, oncolytic virotherapy, and targeted nanomedicines
Fereshteh Rahdan, Fatemeh Abedi, Hassan Dianat‐Moghadam, et al.
Clinical and Experimental Medicine (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy
Tao Dong, Jaimin R. Shah, Abraham T. Phung, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3157-3157
Open Access | Times Cited: 5
A viral attack on brain tumors: the potential of oncolytic virus therapy
Kasra Mokhtarpour, Milad Akbarzadehmoallemkolaei, Nima Rezaei
Journal of NeuroVirology (2024) Vol. 30, Iss. 3, pp. 229-250
Closed Access | Times Cited: 1
The implications of oncolytic viruses targeting fibroblasts in enhancing the antitumoural immune response
Ibrahem Al-Obaidi, Ciaran Sandhu, Bilal Javaid Qureshi, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e39204-e39204
Open Access | Times Cited: 1
Molecular Mechanisms and Animal Models of HBV-Related Hepatocellular Carcinoma: With Emphasis on Metastatic Tumor Antigen 1
Yung‐Tsung Li, Hui-Lin Wu, Chun‐Jen Liu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9380-9380
Open Access | Times Cited: 9
Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy
М. А. Дымова, Anna S. Kichkailo, Elena V. Kuligina, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 151-151
Open Access | Times Cited: 6
Potential Impact of N6-Methyladenosine RNA Methylation on Vision Function and the Pathological Processes of Ocular Diseases: New Discoveries and Future Perspectives
Xiaohua Li, Binyun Ma, Mengyu Liao, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 7, pp. 207-207
Open Access | Times Cited: 5
Histone Deacetylase Inhibitor Panobinostat Benefits the Therapeutic Efficacy of Oncolytic Herpes Simplex Virus Combined with PD-1/PD-L1 Blocking in Glioma and Squamous Cell Carcinoma Models
Yinglin Wu, Xiaohong Chen, Lei Wang, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2796-2796
Open Access | Times Cited: 5
Preclinical evaluation of oncolytic potential human rotavirus Wt 1-5 in gastric adenocarcinoma
Henry Sossa-Rojas, Pedro Gabriel Franco-Maz, Carlos Manuel Zapata-Acevedo, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0285543-e0285543
Open Access | Times Cited: 2
Hepatitis B Virus X Protein Modulates p90 Ribosomal S6 Kinase 2 by ERK to Promote Growth of Hepatoma Cells
Ning Han, Qingbo Zhang, Xiaoqiong Tang, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1182-1182
Open Access | Times Cited: 1
Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells
Jiayao Li, Tian Tian, Bing Han, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 34, pp. 5038-5053
Open Access | Times Cited: 1
Immunotherapy in Oncology: A Comprehensive Overview from a Pathological Perspective
Cristina Díaz del Arco
Interdisciplinary cancer research (2024)
Closed Access
The use of viruses in anti-cancer therapies – new achievements and challenges
Małgorzata Grudnik, Katarzyna Grudnik, Maciej Słomian, et al.
Annales Academiae Medicae Silesiensis (2024) Vol. 2(nr specj.), Iss. 2, pp. 20-26
Open Access
The Potential of Oncolytic Virotherapy in the Treatment of Head and Neck Cancer: A Comprehensive Review
Francesca Spirito, Riccardo Nocini, Giorgio Mori, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12990-12990
Open Access
Page 1 - Next Page

Scroll to top